decisionhealth Newsletters, Part B News - 2009 Issue 1 (January)
Stable ASP list means most drugs will get a price boost
Subscribe or sign in to view the full article.
Article Overview
This article explains CMS’s first-quarter 2009 ASP update for Medicare Part B drugs and summarizes how payment amounts changed across commonly billed drug products. It is relevant for coders, billing staff, reimbursement analysts, and practices that administer physician-supplied drugs, especially those tracking quarterly ASP fluctuations and CMS payment updates. The piece presents a high-level market overview along with tables of the largest payment increases and decreases for selected drugs.
Why This Topic Matters
Quarterly ASP updates can affect reimbursement for frequently administered drugs and can influence billing, budgeting, and payment monitoring for practices and suppliers. Understanding which drug products changed and the general direction of those changes helps stakeholders stay current with Medicare Part B payment updates.
Article Sections
-
CMS first-quarter 2009 ASP update overview
Summarizes the overall direction of payment changes in CMS’s quarterly ASP list and notes the general stability of average drug prices. This section also places the update in the context of Medicare Part B drug payment.
-
Top billed drugs with a payment increase
Lists selected commonly billed drug products that saw higher payment amounts in the first quarter of 2009. The section presents comparative pricing information and change percentages.
-
Top billed drugs with a payment decrease
Lists selected commonly billed drug products that saw lower payment amounts in the first quarter of 2009. The section presents comparative pricing information and change percentages.
-
Source and timing notes
Identifies the CMS ASP list as the underlying source and notes the effective date range for the quarter covered. It also explains the general basis used for selecting the highlighted drug changes.
What You Will Learn
- What CMS’s first-quarter 2009 ASP update covered
- How the article frames overall payment movement for Medicare Part B drugs
- Which categories of drug products are highlighted as having larger payment changes
- How the article organizes quarterly increase and decrease summaries
- What source material and time period were used for the comparison
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Physician office administrators
- Drug inventory and purchasing staff
- Revenue cycle analysts
- Healthcare finance professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com